CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.000377 (-5.91%)
At close: Oct 16, 2026
CERO Market Cap
CERO has a market cap or net worth of $455.53 thousand as of October 16, 2026. It is the 50,342nd most valuable company in the world and the 6,949th biggest in the United States. Its market cap has decreased by 90.61% in one year.
Market Cap
455.53K
Enterprise Value
16.82M
Revenue
n/a
Global Rank
Country Rank
#6,949 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 30, 2021, CERO's market cap has decreased from 222.99M to 455.53K, a decrease of -99.80%. That is a compound annual growth rate of -71.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 455.53K | -67.76% |
| Dec 31, 2025 | 1.41M | -87.73% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
| Nov 30, 2021 | 222.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioMedix | 739.29K |
| SQZ Biotechnologies Company | 707.79K |
| Regenerative Medical Technology Group | 596.86K |
| Orgenesis | 555.63K |
| Altamira Therapeutics | 514.39K |
| Neon Bloom | 488.20K |
| ZyVersa Therapeutics | 388.60K |
| Actavia Life Sciences | 385.91K |